| 000 | 01331 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250518080343.0 | ||
| 264 | 0 | _c20210308 | |
| 008 | 202103s 0 0 eng d | ||
| 022 | _a1090-2120 | ||
| 024 | 7 |
_a10.1016/j.bioorg.2019.103547 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Cheng | |
| 245 | 0 | 0 |
_aDesign and optimization of orally spleen tyrosine kinase (SYK) inhibitors for treatment of solid tumor. _h[electronic resource] |
| 260 |
_bBioorganic chemistry _c01 2020 |
||
| 300 |
_a103547 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aSyk Kinase _xantagonists & inhibitors |
| 700 | 1 | _aWang, Xin | |
| 700 | 1 | _aLi, Yao | |
| 700 | 1 | _aWang, Tianqi | |
| 700 | 1 | _aHuang, Zhi | |
| 700 | 1 | _aQin, Zhongxiang | |
| 700 | 1 | _aYang, Shengyong | |
| 700 | 1 | _aXiang, Rong | |
| 700 | 1 | _aFan, Yan | |
| 773 | 0 |
_tBioorganic chemistry _gvol. 95 _gp. 103547 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bioorg.2019.103547 _zAvailable from publisher's website |
| 999 |
_c30493088 _d30493088 |
||